Mark Watson
Direttore/Membro del Consiglio presso ABRDN HEALTHCARE OPPORTUNITIES FUND
Posizioni attive di Mark Watson
Società | Posizione | Inizio | Fine |
---|---|---|---|
ABRDN HEALTHCARE OPPORTUNITIES FUND | Direttore/Membro del Consiglio | 09/06/2022 | - |
Independent Dir/Board Member | 09/06/2022 | - | |
H. Lee Moffitt Cancer Center & Research Institute, Inc.
H. Lee Moffitt Cancer Center & Research Institute, Inc. Miscellaneous Commercial ServicesCommercial Services H. Lee Moffitt Cancer Center & Research Institute, Inc. provides research & contributions to clinical trials, prevention and cancer control. The firm operates as National Cancer Institute (NCI) Comprehensive Cancer Center. The company was founded by Lee H. Moffitt in 1981 and is headquartered in Tampa, FL. | Direttore/Membro del Consiglio | 01/01/2009 | - |
Storia della carriera di Mark Watson
Precedenti posizioni note di Mark Watson
Società | Posizione | Inizio | Fine |
---|---|---|---|
INHIBITOR THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 01/01/2014 | 13/12/2022 |
BIODELIVERY SCIENCES INTERNATIONAL, INC. | Direttore/Membro del Consiglio | 01/01/2017 | 02/01/2022 |
SYKES ENTERPRISES, INCORPORATED | Direttore/Membro del Consiglio | 01/01/2018 | 02/01/2021 |
Statistiche
Distribuzione geografica
Stati Uniti | 6 |
Posizioni
Director/Board Member | 5 |
Independent Dir/Board Member | 1 |
Settori
Health Technology | 3 |
Miscellaneous | 2 |
Technology Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
INHIBITOR THERAPEUTICS, INC. | Health Technology |
Aziende private | 4 |
---|---|
abrdn Healthcare Opportunities Fund
abrdn Healthcare Opportunities Fund Investment Trusts/Mutual FundsMiscellaneous Tekla Healthcare Opportunities Fund operates as a closed-end investment fund and investment trust. The trust's investment objective is to seek current income and long-term capital appreciation through investing in companies engaged in the healthcare industry, including equity securities, debt securities and pooled investment vehicles. The Trust was founded on April 2, 2014 and is headquartered in Boston, MA. | Miscellaneous |
BioDelivery Sciences International, Inc.
BioDelivery Sciences International, Inc. Pharmaceuticals: MajorHealth Technology BioDelivery Sciences International, Inc. operates as a pharmaceutical company engaged in the development and commercialization of new applications of approved therapeutics to address important unmet medical needs. Its products include Symproic and Belbuca. The company was founded on January 6, 1997 and is headquartered in Raleigh, NC. | Health Technology |
Sykes Enterprises, Inc.
Sykes Enterprises, Inc. Information Technology ServicesTechnology Services Sykes Enterprises, Inc. engaged in the provision of multichannel demand generation and global customer engagement services. It operates through the following segments: Americas, Europe, the Middle East and Africa (EMEA), and Other. The Americas segment includes the United States, Canada, Latin America, Australia, and the Asia Pacific Rim; and offers outsourced customer engagement solutions and technical staffing. The EMEA segment covers outsourced customer engagement solutions and fulfilment services. The Other segment represents other items such as corporate and other costs, other income and expense, and income taxes. The company was founded by John H. Sykes in 1977 and was headquartered in Miami, FL. | Technology Services |
H. Lee Moffitt Cancer Center & Research Institute, Inc.
H. Lee Moffitt Cancer Center & Research Institute, Inc. Miscellaneous Commercial ServicesCommercial Services H. Lee Moffitt Cancer Center & Research Institute, Inc. provides research & contributions to clinical trials, prevention and cancer control. The firm operates as National Cancer Institute (NCI) Comprehensive Cancer Center. The company was founded by Lee H. Moffitt in 1981 and is headquartered in Tampa, FL. | Commercial Services |
- Borsa valori
- Insiders
- Mark Watson
- Esperienza